Plant Summary


  Plant Information

TCMBank_ID:

TCMBANKHE007498

ID:

TCMBANKHE007498

植物拉丁名:

Thuja orientalis
显示图片

功能与主治:

To dispel wind and eliminate damp, resolve toxin and cure sores./Wind impediment, joint running wind, cholera cramp, gum swelling and pain.

药用植物名:

侧柏枝节

药用部位:

branchlet

TCM_ID_id:

3095


   植物对应的化合物
化合物ID 化合物名 别名 分子式 分子质量 Smiles
TCMBANKIN003305 3beta,20(R),5-alkenyl-stigmastol 414.79
TCMBANKIN005818 Thujopsadiene thujopsadiene; AC1O575L; 2,4a,8,8-tetramethyl-1,1a,4,5-tetrahydrocyclopropa[j]naphthalene; HIRCZOSUMSSTDU-UHFFFAOYSA-N C15H22 202.33 g/mol CC1=CCC2(CC=CC(C23C1C3)(C)C)C
TCMBANKIN018561 Wighteone AIDS071696; AIDS-071696; 5,7-dihydroxy-3-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)chromen-4-one; wighteone; 5,7-dihydroxy-3-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)-4-chromenone; C10542; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-3-(4-hydroxyphenyl)-6-(3-methyl-2-butenyl)-; 51225-30-0; 5,7-dihydroxy-3-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)chromone C20H18O5 338.35 CC(=CCC1=C(C2=C(C=C1O)OC=C(C2=O)C3=CC=C(C=C3)O)O)C
TCMBANKIN022149 Chamissonin diacetate [(3aR,4R,5E,7R,9E,11aS)-7-acetoxy-6,10-dimethyl-3-methylene-2-oxo-3a,4,7,8,11,11a-hexahydrocyclodeca[b]furan-4-yl] acetate; [(3aR,4R,5E,7R,9E,11aS)-7-acetyloxy-6,10-dimethyl-3-methylidene-2-oxo-3a,4,7,8,11,11a-hexahydrocyclodeca[b]furan-4-yl] acetate; C09356; acetic acid [(3aR,4R,5E,7R,9E,11aS)-7-acetoxy-2-keto-6,10-dimethyl-3-methylene-3a,4,7,8,11,11a-hexahydrocyclodeca[d]furan-4-yl] ester; 24112-95-6; acetic acid [(3aR,4R,5E,7R,9E,11aS)-7-acetoxy-6,10-dimethyl-3-methylene-2-oxo-3a,4,7,8,11,11a-hexahydrocyclodeca[b]furan-4-yl] ester; chamissonin diacetate; [(3aR,4R,5E,7R,9E,11aS)-7-acetyloxy-6,10-dimethyl-3-methylidene-2-oxo-3a,4,7,8,11,11a-hexahydrocyclodeca[b]furan-4-yl] ethanoate C19H24O6 348.39 CC1=CCC(C(=CC(C2C(C1)OC(=O)C2=C)OC(=O)C)C)OC(=O)C
TCMBANKIN022954 cupreine C19H22N2O2 310.4 g/mol C=CC1CN2CCC1CC2C(C3=C4C=C(C=CC4=NC=C3)O)O
TCMBANKIN024165 welensalifactor f1 C54H80N2O6S2 CC12CCC3C(C1CCC2C4=COC=C4)CCC5C3(C(CC(C5)SCCCN)OC(=O)C(=O)OC6CC(CC7C6(C8CCC9(C(C8CC7)CCC9C1=COC=C1)C)C)SCCCN)C
TCMBANKIN024177 mayurone C14H20O 204.31 g/mol CC1(CCCC2(C13CC3C(=O)C=C2)C)C
TCMBANKIN030527 curcumenether (+)-Curcumene ether C15H22O 218.33 g/mol CC1=CC=C(C=C1)C2(CCCC(O2)(C)C)C
TCMBANKIN036828 Wedelolactone NCGC00163667-01; N2131; UNII-0K6L725GNS; 1,8,9-Trihydroxy-3-methoxycoumestan; Ambotz524-12-9; CTK8G3781; 0K6L725GNS; Wedelolactone, European Pharmacopoeia (EP) Reference Standard; SC-67595; ZINC6483512; IKK Inhibitor II, Wedelolactone; GTPL5551; CCG-208289; NCGC00163667-02; SR-05000002318-2; Wedelolactone, >=98% (HPLC), powder; 7-Methoxy-5,11,12-trihydroxy-coumestan; AKOS015897173; AN-45548; C10541; AC1NQZ4Z; CHEMBL97453; BRD-K53635676-001-02-3; 1,8,9-Trihydroxy-3-methoxy-benzo[4,5]furo[3,2-c]chromen-6-one; 7-Methoxy-5,11,12-trihydroxycoumestan; CHEBI:10037; DTXSID60200408; 1,8,9-trihydroxy-3-methoxy-6-benzofurano[3,2-c]chromenone; W4016_SIGMA; Wedelolactone, <i>Eclipta alba; FT-0698529; SCHEMBL601220; MFCD07778564; SR-05000002318; CM-842; 5,11,12-Trihydroxy-7-methoxycoumestan; K00058; 1,8,9-Trihydroxy-3-methoxy-6H-benzofuro[3,2-c][1]benzopyran-6-one; NCGC00163667-03; Wedelolactone, Eclipta alba; BRD-K53635676-001-01-5; 7-methoxy-5,11,12-trihydroxy-coumestan; Wedelolactone; 524W129; SMP2_000112; 1,8,9-trihydroxy-3-methoxy-benzofurano[3,2-c]chromen-6-one; 1,8,9-trihydroxy-3-methoxy-[1]benzofuro[3,2-c]chromen-6-one; 524-12-9; MolPort-003-960-187; 6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 1,8,9-trihydroxy-3-methoxy-; 1,8,9-trihydroxy-3-methoxy-benzofuro[3,2-c]chromen-6-one; HMS2043P19; LMPK12090046; D0F8QJ; BDBM50096619; Wedelolactone, analytical standard; I07-0266; 6H-Benzofuro[3,2-c][1]benzopyran-6-one,1,8,9-trihydroxy-3-methoxy-; 1,8,9-Trihydroxy-3-methoxy-6H-[1]benzofuro[3,2-c]chromen-6-one; 1,8,9-trihydroxy-3-methoxy-[1]benzoxolo[3,2-c]chromen-6-one; Wedelolactone; 7-Methoxy-5,11,12-trihydroxy-coumestan C16H10O7 314.246 c1(O[H])c([H])c(c(C(=O)Oc(c([H])c(OC([H])([H])[H])c([H])c2O[H])c23)c3o4)c4c([H])c1O[H]
TCMBANKIN038148 beta-Cuparenone β-cuparenone C15H20O 216.319 C([H])([H])([H])c1c([H])c([H])c([C@]2(C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C(=O)C2([H])[H])c([H])c1[H]
TCMBANKIN039868 isocurcumenol isocurcum enol; LS-64023; MolPort-039-338-608; ZINC15160861; 24063-71-6; Isocurcumenol C15H22O2 234.334 [C@@]1([H])(C(=C([H])[H])C2([H])[H])[C@@]3([C@@]([H])(C([H])([H])[H])C([H])([H])C1([H])[H])O[C@]2(O[H])\C(=C(\C([H])([H])[H])/C([H])([H])[H])\C3([H])[H]
TCMBANKIN039991 alpha-cuparenone α-cuparenone C15H20O 216.32 g/mol CC1=CC=C(C=C1)C2(CCC(=O)C2(C)C)C
TCMBANKIN040187 trans-Widdrol alpha-epoxie C15H26O2 238.366 C1([H])([H])C([H])([H])[C@]2(C([H])([H])[H])[C@@]3([C@@]([H])(O3)C([H])([H])[C@@](C([H])([H])[H])(O[H])C([H])([H])C2([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C1([H])[H]
TCMBANKIN040838 beta-cuparenol β-cuparenol C15H22O 218.33 g/mol CC1=CC=C(C=C1)C2(CC(CC2(C)C)O)C
TCMBANKIN044816 gamma-cuparenol C15H22O 218.33 g/mol CC1(CCCC1(C)C2=CC=C(C=C2)CO)C
TCMBANKIN045107 beta-Isobiotol β-isobiotol C15H24O 220.35 C1([H])([H])C([H])([H])C(=C([H])[H])[C@]2([H])C([H])([H])[C@@]13[C@]([H])(C2(C([H])([H])[H])C([H])([H])[H])C([H])([H])[C@](O[H])([H])[C@]3(C([H])([H])[H])[H]
TCMBANKIN045207 cis-Widdrol alpha-epoxide cis-widdrol α-epoxide; cis-widdrol alpha-epoxide C15H26O2 238.366 C1([H])([H])C([H])([H])[C@]2(C([H])([H])[H])[C@]3([C@]([H])(O3)C([H])([H])[C@@](C([H])([H])[H])(O[H])C([H])([H])C2([H])[H])C(C([H])([H])[H])(C([H])([H])[H])C1([H])[H]
TCMBANKIN045427 alpha-cuprenene α-cuprenene C15H24 204.351 CC1=CC=C(CC1)C2(CCCC2(C)C)C
TCMBANKIN047594 alpha-biotol α-biotol C15H24O 220.35 g/mol CC1CC(C2C13CC=C(C(C3)C2(C)C)C)O
TCMBANKIN047964 trans-Widdrol α-epoxide
TCMBANKIN049185 dehydro-alpha-curcumene 4999-58-0; AC1NSUA4; 1-methyl-4-(6-methylhepta-1,5-dien-2-yl)benzene; Bisabola-1,3,5,7(14),10-pentaene; dehydro-α-curcumene; YAZBKDRDYPAXAO-UHFFFAOYSA-N C15H20 200.32 g/mol CC1=CC=C(C=C1)C(=C)CCC=C(C)C
TCMBANKIN049942 beta-Biotol β-biotol C15H24O 220.35 [C@]1([H])(O[H])[C@]2([H])[C@@]3(C([H])([H])[C@]([H])(C(=C([H])[H])C([H])([H])C3([H])[H])C2(C([H])([H])[H])C([H])([H])[H])[C@]([H])(C([H])([H])[H])C1([H])[H]
TCMBANKIN058224 Cupressuflavone 8-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-8-chromenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-chromenone; cupressuflavone ; 3952-18-9; 8-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one; 8-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-keto-chromen-8-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromone; ST5331567; Cupressiflavone; C10034; 8-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-8-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one; 8,8''-Biapigenin C30H18O10 538.46 C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)C4=C(C=C(C5=C4OC(=CC5=O)C6=CC=C(C=C6)O)O)O)O
TCMBANKIN059652 gamma-cuparenol C15H22O 218.33 g/mol CC1(CCCC1(C)C2=CC=C(C=C2)CO)C
TCMBANKIN059654 6892-80-4 C15H26O 222.37 g/mol CC1(CCCC2(C1=CCC(CC2)(C)O)C)C
TCMBANKIN059910 alpha-Cuparenol C15H22O 218.33 CC1=CC=C(C=C1)C2(CCC(C2(C)C)O)C
TCMBANKIN059972 gamma-cuprenene;γ-cuprenene C15H24 CC1=CCC(=CC1)C2(CCCC2(C)C)C
TCMBANKIN059999 beta-Chamigrene C15H24 204.35 g/mol CC1=CCC2(CC1)C(=C)CCCC2(C)C
TCMBANKIN060001 thujopsene C15H24 204.35 g/mol CC1=CCC2(CCCC(C23C1C3)(C)C)C
TCMBANKIN060467 (6Z,10S)-3-isopropylidene-6,10-dimethyl-cyclodec-6-ene-1,4-quinone C15H22O2 234.33 CC1CCC=C(CC(=O)C(=C(C)C)CC1=O)C
TCMBANKIN061333 Izoteolin Isoteolin; ST057702; 4H-Dibenzo(de,g)quinolinediol, 5,6,6a,7-tetrahydro-2,9(or 2,10)-dimethoxy-6-methyl-, (S)-; 95508-61-5; TNP00331; C09541; NCGC00142559-01; Isoboldine; Isoteoline; 6aalpha-Aporphine-1,9-diol, 2,10-dimethoxy-; NCGC00017381-01; isoboldine C19H21NO4 327.4 g/mol CN1CCC2=CC(=C(C3=C2C1CC4=CC(=C(C=C43)OC)O)O)OC
TCMBANKIN061453 31098-60-9 mecambridine;(-)-mecambridine;27341-28-2; 6H-Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizine-12-methanol, 5,8,13,13a-tetrahydro-10,11,14-trimethoxy-, (S)- C22H25NO6 399.44 COC1=C(C(=C2CC3C4=C(C5=C(C=C4CCN3CC2=C1)OCO5)OC)CO)OC

   植物对应的疾病
疾病ID 病名 疾病类型 MeSH 参考文献

   植物对应的靶点
靶点ID 基因名 基因别名 描述 染色体位置 Map_Location 基因类型